| Literature DB >> 34977860 |
Zheng Gong1, Ming Cheng1, Jose R Botella1.
Abstract
CRISPR/Cas-based genome editing technologies have the potential to fast-track large-scale crop breeding programs. However, the rigid cell wall limits the delivery of CRISPR/Cas components into plant cells, decreasing genome editing efficiency. Established methods, such as Agrobacterium tumefaciens-mediated or biolistic transformation have been used to integrate genetic cassettes containing CRISPR components into the plant genome. Although efficient, these methods pose several problems, including 1) The transformation process requires laborious and time-consuming tissue culture and regeneration steps; 2) many crop species and elite varieties are recalcitrant to transformation; 3) The segregation of transgenes in vegetatively propagated or highly heterozygous crops, such as pineapple, is either difficult or impossible; and 4) The production of a genetically modified first generation can lead to public controversy and onerous government regulations. The development of transgene-free genome editing technologies can address many problems associated with transgenic-based approaches. Transgene-free genome editing have been achieved through the delivery of preassembled CRISPR/Cas ribonucleoproteins, although its application is limited. The use of viral vectors for delivery of CRISPR/Cas components has recently emerged as a powerful alternative but it requires further exploration. In this review, we discuss the different strategies, principles, applications, and future directions of transgene-free genome editing methods.Entities:
Keywords: CRISPR (clustered regularly interspaced short palindromic repeat)/Cas9 (CRISPR associated protein 9)-mediated genome editing; RNPs; crops; genome editing; non-GM approach; transgene-free; virus induced genome editing
Year: 2021 PMID: 34977860 PMCID: PMC8715957 DOI: 10.3389/fgeed.2021.817279
Source DB: PubMed Journal: Front Genome Ed ISSN: 2673-3439
FIGURE 1Methods with potential for transgene-free genome editing in plants using in vitro/chemically synthesized Cas mRNA and gRNA, DNA templates or Cas/gRNA ribonucleoproteins (RNPs) (Created with BioRender.com). The asterisk (*) indicates methods which have not been experimentally tested. (A,B) Established, GM-free systems for the delivery of CRISPR/Cas/gRNA into plants. (A) Polyethylene glycol (PEG)-mediated delivery of preassembled Cas/gRNA RNPs into plant protoplasts. PEG mediates the uptake of Cas/gRNA RNPs into protoplast cells. The Cas/gRNA complex enters the nucleus and induces genome editing. The protoplasts are then regenerated to produce transgene-free gene edited plants. (B) Particle bombardment-based delivery of preassembled Cas/gRNA RNPs, Cas mRNA plus gRNA or Cas/gRNA DNA expression cassettes. The CRISPR components are loaded onto particles and introduced into plant cells using a gene gun or biolistic device. The Cas/gRNA complexes are localized to the nucleus and induce genome editing. Regeneration from bombarded plant tissue without selection produces gene edited plants whilst avoiding transgenesis (in a large proportion of the regenerated plants). (C,D) Potential delivery systems for the application of transgene-free genome editing in plants. (C) Common types of nanoparticles currently used in biotechnology. Nanoparticles, such as carbon nanotubes, have been explored as delivery systems for DNA/RNA and protein into mesophyll through stomata pores (around 10 nm). Other nanoparticles, larger than 10 nm, can be introduced into plants by chemical, or physical methods. Therefore, nanoparticles could act as a carrier for the delivery of genome editing reagents into plant cells. Note that nanoparticles are not restricted to spherical forms. (D) Plant meristematic microinjection using phytoinjectors. Phytoinjectors could potentially be adopted for the injection of Cas mRNA and gRNA, RNPs or nanoparticle-bound genome editing reagents. (E–G) Potential target cell types and organs for transgene-free genome editing. (E) Gene editing in plant zygotes. The isolated sperm and egg cells are electro-fused to form zygotes. Early zygotes lack cell walls and the Cas/gRNA RNPs are transfected with PEG. Zygotes are then regenerated to obtain gene edited plants. (F) Gene editing using pollen. Nanoparticles carrying Cas mRNA and gRNAs or Cas/gRNA RNPs could be transfected into pollen through magnetofection. The transfected pollen is used to pollinate a flower to produce transgene-free gene edited seeds. (G) Non-transgenic delivery/transient expression of developmental regulators and CRISPR/Cas reagents in plant organs may produce gene edited, de novo meristems which can be cultured to obtain gene edited seeds.
FIGURE 2Virus induced genome editing (VIGE) systems in plants (Created with BioRender.com). (A) VIGE through gRNA expression. The gRNA is cloned into the complementary DNA (cDNA) of an RNA virus genome in a binary vector. A. tumefaciens carrying the binary vector with the recombinant viral cDNA is agroinfiltrated into a leaf on Cas9 transgenic plants. The viral cDNA is expressed to produce viral RNA which self-replicates. gRNAs transcribed from the viral vector are bound by the Cas9 protein expressed from the plant integrated transgene. The Cas9/gRNA complex is localized in the nucleus where it induces targeted gene editing. Viral genomes are encapsidated into recombinant virions which exit the plant cell inducing systemic infection. When gRNAs are fused to FT or tRNAs, the augmented gRNA may travel and enter meristematic cells. Gene editing in meristematic cells can produce edited Cas9 transgenic seeds. Alternatively, systemically infected leaf tissue can be used for plant regeneration. Genome edited Cas9 transgenic seeds are obtained from regenerated plants. The gene edited transgenic Cas9 progenies can be backcrossed with wild type (WT) plants to segregate the Cas9 transgene. (B) Transgene-free VIGE system. Certain viruses are capable of carrying and expressing cassettes containing Cas9 and gRNAs. The Cas9 gene and gRNA are introduced into the viral genome cDNA in a binary vector and agroinfiltrated into WT plants. The viral cDNA is expressed to produce viral RNA which self-replicates. Cas9 protein and gRNA are transiently expressed from the viral genome to form a complex. The Cas9/gRNA complex is localized to the nucleus for targeted genome editing. Viral genomes are encapsidated into recombinant virions exiting the plant cell and induces systemic infection. Systemically infected leaf tissue can be used for plant regeneration. The regenerated plants produce transgene-free gene-edited seeds.